St. Jude Medical, Inc.  

(Public, NYSE:STJ)   Watch this stock  
Find more results for Stuart M. Essig
62.94
+0.32 (0.51%)
After Hours: 62.94 0.00 (0.00%)
Apr 22, 5:07PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 62.74 - 64.15
52 week 40.44 - 68.79
Open 62.88
Vol / Avg. 0.00/1.97M
Mkt cap 18.20B
P/E 24.45
Div/yield 0.27/1.72
EPS 2.57
Shares 289.12M
Beta 1.07
Inst. own 87%
Jul 14, 2014
Q2 2014 St. Jude Medical, Inc. Earnings Release (Estimated) Add to calendar
May 1, 2014
St. Jude Medical, Inc. Annual Shareholder Meeting - 9:30AM EDT - Add to calendar
Apr 16, 2014
Q1 2014 St. Jude Medical, Inc. Earnings Release
Apr 16, 2014
Q1 2014 St. Jude Medical, Inc. Earnings Conference Call
Mar 12, 2014
St. Jude Medical, Inc. at Barclays Healthcare Conference
Feb 7, 2014
St. Jude Medical, Inc. 2014 Investor Meeting - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 17.53% 12.58%
Operating margin 22.89% 19.11%
EBITD margin - 30.79%
Return on average assets 9.33% 7.09%
Return on average equity 23.61% 17.37%
Employees 16,000 -
CDP Score - -

Address

ONE ST JUDE MEDICAL DRIVE
ST. PAUL, MN 55117
United States - Map
+1-651-7562000 (Phone)
+1-651-7563301 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

St. Jude Medical, Inc. (St. Jude) develops, manufactures and distributes cardiovascular medical devices. Its principal products in each therapy area are: Cardiac Rhythm Management - tachycardia implantable cardioverter defibrillator systems (ICDs) and bradycardia pacemaker systems (pacemakers); Cardiovascular - vascular products, which include vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories, and structural heart products, which include heart valve replacement and repair products and structural heart defect devices; Atrial Fibrillation - electrophysiology (EP) introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems, and Neuromodulation - neurostimulation products, which include spinal cord and deep brain stimulation devices. In August 2013, St. Jude Medical Inc announced the acquisition of Endosense SA.

Officers and directors

Daniel J. Starks Chairman of the Board, President, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Donald J. Zurbay Chief Financial Officer, Vice President - Finance
Age: 45
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joel D. Becker President - U.S. Division
Age: 45
Bio & Compensation  - Reuters
Eric S. Fain M.D. Group President - St. Jude Medical
Age: 52
Bio & Compensation  - Reuters
Denis M. Gestin President - International
Age: 49
Bio & Compensation  - Reuters
Michael T. Rousseau Chief Operating Officer
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John C. Heinmiller Executive Vice President
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark W. Murphy Vice President - Information Technology, Chief Information Officer
Bio & Compensation  - Reuters
Lisa Andrade Chief Marketing Officer
Bio & Compensation  - Reuters
Scott Thome Vice President - Global Operations and Supply Chain
Bio & Compensation  - Reuters